Product Information
VENLAFAXINE HCL ER 37.5 MG TAB is a generic product labeled by Vertical Pharmaceuticals, LLC, priced at $0.4262 per EA under NDC 68025007930. Its NADAC has been published 485 times since Jan 11, 2017.
FDA first approved this application on May 20, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
37.5 mg/1
Manufacturer
Vertical Pharmaceuticals, LLCNDC
68025007930
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA022104FDA Approved
5/20/2008
TE Code
AB
On Market Since
4/29/2010
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL ER 37.5 MG TAB has been published 485 times since Jan 11, 2017, and over the history we have for it it has declined 84.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4262 per EA |
|---|---|
| All-time high | $5.0834 (Nov 14, 2018) |
| All-time low | $0.3039 (Jan 22, 2025) |
| 52-week high | $0.6512 |
| 52-week low | $0.3302 |
| Median price | $2.6573 |
| Average price | $2.7912 |
| Largest weekly change | +62.8% (May 18, 2022) |
| Weeks tracked | 485 |
| Tracking since | Jan 11, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
+28.8%
1Y
-34.6%
3Y
-49.2%
5Y
-90.6%
All
-84.0%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 83% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL ER 37.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL ER 37.5 MG TAB, manufactured by Vertical Pharmaceuticals, LLC, is $0.4262 per EA (NDC 68025007930), effective May 20, 2026.
How has the price of VENLAFAXINE HCL ER 37.5 MG TAB changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL ER 37.5 MG TAB has declined 84.0%. It has been tracked across 485 weekly CMS publications since Jan 11, 2017.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL ER 37.5 MG TAB?
Since Jan 11, 2017, the NADAC for VENLAFAXINE HCL ER 37.5 MG TAB has ranged from a low of $0.3039 (Jan 22, 2025) to a high of $5.0834 (Nov 14, 2018), with a median of $2.6573 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL ER 37.5 MG TAB?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VENLAFAXINE HCL 37.5 MG TABLET, is $0.0743 per EA — about 83% below VENLAFAXINE HCL ER 37.5 MG TAB.
Who manufactures VENLAFAXINE HCL ER 37.5 MG TAB?
VENLAFAXINE HCL ER 37.5 MG TAB (NDC 68025007930) is labeled by Vertical Pharmaceuticals, LLC, and CMS classifies it as a generic product.